{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:29:43Z","timestamp":1722889783562},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,21]],"date-time":"2010-02-21T00:00:00Z","timestamp":1266710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10689-010-9327-8","type":"journal-article","created":{"date-parts":[[2010,2,20]],"date-time":"2010-02-20T10:09:58Z","timestamp":1266660598000},"page":"291-295","source":"Crossref","is-referenced-by-count":2,"title":["Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence"],"prefix":"10.1007","volume":"9","author":[{"name":"On behalf of the Group for Assessment for Hereditary Cancer of Valencian Community","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Esteban Carde\u00f1osa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascual","family":"Bolufer Gilabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"de Juan Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarai","family":"Palanca Suela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Barrag\u00e1n Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Gonz\u00e1lez Anguix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Lerma Alejos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Chirivella Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Segura Huerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Guill\u00e9n Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Mart\u00ednez de Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Cuevas Cuerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Salas Trejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,21]]},"reference":[{"key":"9327_CR1","volume-title":"Federaci\u00f3n de Sociedades Espa\u00f1olas de Oncolog\u00eda","author":"FESEO","year":"2002","unstructured":"FESEO (2002) Tercer Libro Blanco de la Oncolog\u00eda. In: Biete Sol\u00e1 A, Palacios Eito A, Calvo Manuel FA (eds) Federaci\u00f3n de Sociedades Espa\u00f1olas de Oncolog\u00eda. FESEO, Madrid"},{"key":"9327_CR2","volume-title":"Programa de Consejo Gen\u00e9tico en el C\u00e1ncer. Grupo de C\u00e1ncer Hereditario","author":"Conselleria de Sanitat","year":"2003","unstructured":"Conselleria de Sanitat (2003) Programa de Consejo Gen\u00e9tico en el C\u00e1ncer. Grupo de C\u00e1ncer Hereditario. Plan Oncol\u00f3gico, Comunidad Valenciana"},{"key":"9327_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"9327_CR4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"9327_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng1107","volume":"33","author":"A Balmain","year":"2003","unstructured":"Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33:238\u2013244","journal-title":"Nat Genet"},{"key":"9327_CR6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jama.279.12.922","volume":"279","author":"KE Malone","year":"1998","unstructured":"Malone KE, Daling JR, Thompson JD et al (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35\u00a0years and in women before age 45\u00a0years with first-degree family history. JAMA 279:922","journal-title":"JAMA"},{"key":"9327_CR7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.1627","volume":"97","author":"M la Hoya De","year":"2002","unstructured":"De la Hoya M, Osorio A, Godino J et al (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466\u2013471","journal-title":"Int J Cancer"},{"key":"9327_CR8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9327_CR9","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0511301103","volume":"103","author":"S Simchoni","year":"2006","unstructured":"Simchoni S, Friedman E, Kaufman B et al (2006) Familial clustering of site-specific cancer risk associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci USA 103:3770\u20133774","journal-title":"Proc Natl Acad Sci USA"},{"issue":"343","key":"9327_CR10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"19","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et al (1994) Risk of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium. Lancet 19(343):692\u2013695","journal-title":"Lancet"},{"key":"9327_CR11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity abd penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Tha Breast cancer linkage consortium. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"9327_CR12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/gepi.10261","volume":"25","author":"AC Antoniou","year":"2003","unstructured":"Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190\u2013202","journal-title":"Genet Epidemiol"},{"key":"9327_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1025428807472","volume":"81","author":"P Aretini","year":"2003","unstructured":"Aretini P, D\u2032Andrea E, Pasini E et al (2003) Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutations. Breast Cancer Res Treat 81:71\u201379","journal-title":"Breast Cancer Res Treat"},{"key":"9327_CR14","unstructured":"Conseller\u00eda de Sanitat Generalitat de Valencia (2008) C\u00e1ncer hereditario de mama y ovario. Gu\u00eda de Pr\u00e1ctica Cl\u00ednica en C\u00e1ncer hereditario. Plan Oncol\u00f3gico Comunidad valenciana. Oficina del Plan del C\u00e1ncer. Direcci\u00f3n General de Salud P\u00fablica: 31\u201354"},{"key":"9327_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-007-9818-y","volume":"112","author":"E Esteban","year":"2007","unstructured":"Esteban E, Bolufer P, Palanca S et al (2007) Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and\/or ovarian cancer families of Eastern Spain. Breast Cancer Res Treat 112:69\u201373","journal-title":"Breast Cancer Res Treat"},{"key":"9327_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1157\/13115767","volume":"130","author":"E Esteban","year":"2008","unstructured":"Esteban E, Bolufer P, Palanca S et al (2008) Mutaciones de BRCA1 y BRCA2 en familias estudiadas en el Programa de Consejo Gen\u00e9tico en el C\u00e1ncer de la Comunidad Valenciana. Med Clin (Barc) 130:121\u2013126","journal-title":"Med Clin (Barc)"},{"key":"9327_CR17","unstructured":"World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects (2004) http:\/\/www.wma.net\/e\/policy\/pdf\/17c.pdf"},{"key":"9327_CR18","unstructured":"The Breast Cancer Information Core Database BIC. http:\/\/research.nhgri.nih.gov\/bic\/Member\/index.shtml"},{"key":"9327_CR19","doi-asserted-by":"crossref","first-page":"10325","DOI":"10.1073\/pnas.90.21.10325","volume":"90","author":"A Ganguly","year":"1993","unstructured":"Ganguly A, Rock MJ, Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. PNAS 90:10325\u201310329","journal-title":"PNAS"},{"key":"9327_CR20","doi-asserted-by":"crossref","unstructured":"Esteban E, Bolufer P, de Juan I et al. (2009) Broad BRCA1 and BRCA2 mutational spectrum and high incidente of recurrent and mutation in the eastern Spain population. Breast Cancer Res Treat doi 10.1007\/s10549-009-0680-y","DOI":"10.1007\/s10549-009-0680-y"},{"key":"9327_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O Diez","year":"2003","unstructured":"Diez O, Osorio A, Duran M et al (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301\u2013312","journal-title":"Hum Mutat"},{"key":"9327_CR22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10038-006-0404-7","volume":"51","author":"M Infante","year":"2006","unstructured":"Infante M, Duran M, Esteban-Carde\u00f1osa E et al (2006) High proportion of novel mutations of BRCA1 and BRCA2 in breast\/ovarian cancer patients from Castilla-Le\u00f3n (central Spain). J Hum Genet 51:611\u2013617","journal-title":"J Hum Genet"},{"key":"9327_CR23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DEC et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a populations series of 649 women with ovariancancer. Am J Hum Genet 68:700\u2013710","journal-title":"Am J Hum Genet"},{"issue":"8","key":"9327_CR24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","volume":"30","author":"DG Evans","year":"2008","unstructured":"Evans DG, Shenton A, Woodward E et al (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 30(8):155","journal-title":"BMC Cancer"},{"key":"9327_CR25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ajhg.2008.02.008","volume":"82","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Spurdle AB, Sinilnikova OM et al (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82:937\u2013948","journal-title":"Am J Hum Genet"},{"key":"9327_CR26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmg.2006.043091","volume":"44","author":"A Smith","year":"2007","unstructured":"Smith A, Moran A, Boyd MC et al (2007) Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 44:10\u201315","journal-title":"J Med Genet"},{"key":"9327_CR27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/522611","volume":"81","author":"AC Antoniou","year":"2007","unstructured":"Antoniou AC, Sinilnikova OM, Simard J et al (2007) RAD51 135G >C modifies breast cancer risk hmong BRCA2 mutation Carriers: results from a combined an\u00e1lisis of 19 studies. Am J Hum Genet 81:1186\u20131200","journal-title":"Am J Hum Genet"},{"key":"9327_CR28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2407-8-32","volume":"8","author":"S Costa","year":"2008","unstructured":"Costa S, Pinto D, Pereira D et al (2008) Importance of TP53 codon 72 and intron 3 duplication 16\u00a0bp polymorphisms in predition of susceptibility on breast cancer. BMC cancer 8:32","journal-title":"BMC cancer"},{"key":"9327_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-009-0316-2","volume":"119","author":"S Palanca","year":"2009","unstructured":"Palanca S, Esteban E, Barrag\u00e1n E et al (2009) CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Res Treat 119:87","journal-title":"Breast Cancer Res Treat"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9327-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9327-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9327-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:01Z","timestamp":1559252761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9327-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,21]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9327"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9327-8","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2010,2,21]]}}}